SL Science Holding Limited (SLBT) Income Statement

NASDAQ: SLBTRevenue, profits, margins and EPS over 3 years.

SLBT 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue−34.7%
$2.2M
2025 · hover or tap a bar for each year
2023: $878,9712024: $3.4M (+282.7%)2025: $2.2M (−34.7%)
20232025
Gross profit−59.9%
$775,062
2025 · hover or tap a bar for each year
2023: $738,0082024: $1.9M (+161.9%)2025: $775,062 (−59.9%)
20232025
Operating income
−$3.8M
2025 · hover or tap a bar for each year
2023: $96,8282024: −$1.2M (−1,335.3%)2025: −$3.8M
20232025
Net income
−$3.8M
2025 · hover or tap a bar for each year
2023: $399,0352024: −$1.2M (−398.6%)2025: −$3.8M
20232025
EPS (diluted)
−$0.01
2025 · hover or tap a bar for each year
2024: $0.002025: −$0.01
20232025
Net profit margin−138.4 pts
−173.8%
2025 · hover or tap a point for each year
2023: 45.4%2024: −35.4% (−80.8 pts)2025: −173.8% (−138.4 pts)
20232025

SLBT revenue and net income

RevenueNet incomeNet margin (right axis)

Where SLBT's revenue goes

2025
Revenue
$2.2M100.0%
Cost of revenue
−$1.4M−64.7%
Gross profit
$775,06235.3%
Research & development
−$2.1M−94.2%
Sales, general & admin
−$2.5M−115.8%
Operating income
−$3.8M−174.6%
Interest & other income
$17,6660.8%
Net income
−$3.8M−173.8%

Each bar shows an amount and its share of revenue. SLBT kept −173.8% of revenue as net income.

SLBT profit margins

GrossOperatingNet

SLBT growth rates

to 2025
1 year3 years5 years10 years
Revenue−34.7%———
Gross profit−59.9%———
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

SLBT income statement

SL Science Holding Limited annual income statement
202520242023
Revenue$2.2M$3.4M$878,971
Cost of revenue$1.4M$1.4M$140,963
Gross profit$775,062$1.9M$738,008
Research & development$2.1M$2.0M$0
Sales, general & admin$2.5M$1.1M$641,180
Total operating expenses$4.6M$3.1M$641,180
Operating income−$3.8M−$1.2M$96,828
Interest income$40,302$45,304$1,612
Income before taxes−$3.8M−$1.1M$532,870
Income taxes−$4$57,635$133,835
Net income−$3.8M−$1.2M$399,035
EBITDA−$3.7M−$1.1M$134,019
EPS (diluted)−$0.01$0.00—
Gross margin35.3%57.5%84.0%
Operating margin−174.6%−35.6%11.0%
Net margin−173.8%−35.4%45.4%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SLBT's financial statements (latest annual report filed December 31, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.

SLBT financial results

In fiscal year 2025 (ended December 31, 2025), SL Science reported revenue of $2.2 million, down 34.7% from the year before. It had a net loss of $3.8 million, a net profit margin of −173.8%. Diluted earnings per share came to −$0.01.

See the SLBT stock overview for the latest quote and news, or the SLBT chart for price history and technical indicators.

SLBT income statement FAQ

What is SL Science's annual revenue?

SL Science reported total revenue of $2.2 million for fiscal year 2025, which ended on December 31, 2025. That was down 34.7% from $3.4 million the previous year.

Is SL Science profitable?

No. SL Science reported a net loss of $3.8 million in fiscal 2025, a net profit margin of −173.8%; its operating margin was −174.6%.

What is SL Science's gross margin?

SL Science's gross margin was 35.3% in fiscal 2025: for every $100 of revenue, SL Science kept $35 after the direct cost of its products and services.

How much does SL Science spend on research and development?

SL Science spent $2.1 million on research and development in fiscal 2025, 94.2% of revenue.

What are SL Science's earnings per share?

SL Science earned $-0.01 per diluted share in fiscal 2025, compared with $-0.00 a year earlier.

When does SL Science's fiscal year end?

SL Science's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on December 31, 2025.

Biotechnology income statements